630 related articles for article (PubMed ID: 17416287)
21. PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy.
Pérez-Herrera N; May-Pech C; Hernández-Ochoa I; Castro-Mañé J; Rojas-García E; Borja-Aburto VH; Castillo-Burguete T; Quintanilla-Vega B
Exp Mol Pathol; 2008 Oct; 85(2):129-34. PubMed ID: 18582459
[TBL] [Abstract][Full Text] [Related]
22. Paraoxonase 1 status in the Thai population.
Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
[TBL] [Abstract][Full Text] [Related]
23. Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
Sonoki K; Iwase M; Sasaki N; Ohdo S; Higuchi S; Matsuyama N; Iida M
Diabetes Res Clin Pract; 2009 Nov; 86(2):117-23. PubMed ID: 19748147
[TBL] [Abstract][Full Text] [Related]
24. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels.
Leduc V; Poirier J
Neurodegener Dis; 2008; 5(3-4):225-7. PubMed ID: 18322397
[TBL] [Abstract][Full Text] [Related]
26. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
27. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
28. Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium.
Constantinides A; Kerstens MN; Dikkeschei BD; van Pelt LJ; Tellis CC; Tselepis AD; Dullaart RP
Eur J Clin Invest; 2012 Nov; 42(11):1235-43. PubMed ID: 22957745
[TBL] [Abstract][Full Text] [Related]
29. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
[TBL] [Abstract][Full Text] [Related]
30. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
31. Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women.
Shidfar F; Ehramphosh E; Heydari I; Haghighi L; Hosseini S; Shidfar S
Int J Food Sci Nutr; 2009 May; 60(3):195-205. PubMed ID: 18608549
[TBL] [Abstract][Full Text] [Related]
32. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
Rajković MG; Barišić K; Juretić D; Grubišić TŽ; Flegar-Meštrić Z; Rumora L
Clin Biochem; 2011 Aug; 44(12):964-8. PubMed ID: 21620813
[TBL] [Abstract][Full Text] [Related]
34. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
35. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
36. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
[TBL] [Abstract][Full Text] [Related]
37. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S
Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
[TBL] [Abstract][Full Text] [Related]
38. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M
Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344
[TBL] [Abstract][Full Text] [Related]
39. Modulation of paraoxonase (PON1) activity.
Costa LG; Vitalone A; Cole TB; Furlong CE
Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
